Loading...
Serum
India Pharmaceutical Trade Intelligence
Who Supplies Serum to India from AUSTRIA
India's serum imports from AUSTRIA total $21.2M across 32 shipments from 9 foreign suppliers. M/S. OCTAPHARMA AG leads with $14.7M in import value; the top 5 suppliers together control 99.5% of this origin. Leading Indian buyers include BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for serum — a diversified sourcing base with multiple active suppliers from AUSTRIA.
Top foreign suppliers (AUSTRIA) — Ranked by import value
M/S. OCTAPHARMA AG is the leading Serum supplier from AUSTRIA to India, with import value of $14.7M across 3 shipments. The top 5 suppliers — M/S. OCTAPHARMA AG, Takeda Pharmaceuticals International AG, OCTAPHARMA AG, M/S. OCTAPHARMA PHARMAZEUTIKA PRODU, OCTA PHARMA AG — collectively account for 99.5% of total import value from this origin.
Top foreign suppliers (AUSTRIA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. OCTAPHARMA AG | $14.7M | 3 | 69.4% |
| 2 | Takeda Pharmaceuticals International AG | $3.5M | 18 | 16.7% |
| 3 | OCTAPHARMA AG | $2.3M | 4 | 11.1% |
| 4 | M/S. OCTAPHARMA PHARMAZEUTIKA PRODU | $370.8K | 1 | 1.7% |
| 5 | OCTA PHARMA AG | $134.5K | 1 | 0.6% |
| 6 | M/S.OCTAPHARMA PHARMAZEUTIKA | $45.7K | 1 | 0.2% |
| 7 | XXTAPXXRMAXXG | $45.4K | 1 | 0.2% |
| 8 | M/S. BIOPHYLL GMBH | $6.6K | 1 | 0.0% |
| 9 | PFIZER MANUFACTURING GMBH | $2 | 2 | 0.0% |
Showing top 9 of 9 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from AUSTRIA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $14.7M | 3 | 69.4% |
| 2 | TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED | $3.2M | 17 | 15.2% |
| 3 | MYLAN LABORATORIES LIMITED | $1.9M | 2 | 8.7% |
| 4 | ALEMBIC PHARMACEUTICALS LIMITED | $476.1K | 1 | 2.2% |
| 5 | PANACEA BIOTEC PHARMA LIMITED | $370.8K | 1 | 1.7% |
| 6 | BAXALTA BIOSCIENCE INDIA PRIVATE LIMITED | $312.8K | 1 | 1.5% |
| 7 | BIOLOGICAL E LIMITED | $179.9K | 2 | 0.8% |
| 8 | BIOLOGICAL E. LIMITED | $45.7K | 1 | 0.2% |
| 9 | ZYDUS LIFESCIENCES LIMITED | $12.9K | 1 | 0.1% |
| 10 | HIMEDIA LABORATORIES PRIVATE LIMITED | $6.6K | 1 | 0.0% |
| 11 | INDIAN INSTITUTE OF TECHNOLOGY MADRAS | $2 | 2 | 0.0% |
Import Statistics
- Import Value
- $21.2M
- Shipments
- 32
- Foreign Suppliers
- 9
- Indian Buyers
- 11
- Avg. Shipment
- $662.7K
Other Serum Import Origins
Frequently Asked Questions — Serum Imports from AUSTRIA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Serum suppliers from AUSTRIA to India?
The top Serum suppliers from AUSTRIA to India include M/S. OCTAPHARMA AG, Takeda Pharmaceuticals International AG, OCTAPHARMA AG. The leading supplier is M/S. OCTAPHARMA AG with import value of $14.7M USD across 3 shipments. India imported Serum worth $21.2M USD from AUSTRIA in total across 32 shipments.
QHow much Serum does India import from AUSTRIA?
India imported Serum worth $21.2M USD from AUSTRIA across 32 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Serum from AUSTRIA?
The main Indian buyers of Serum sourced from AUSTRIA include BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, TAKEDA BIOPHARMACEUTICALS INDIA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED. The largest buyer is BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED with $14.7M in imports across 3 shipments.
QWhat is the total value of Serum imports from AUSTRIA to India?
The total value of Serum imports from AUSTRIA to India is $21.2M USD, across 32 shipments and 9 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: AUSTRIA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Serum.
- 2.Supplier/Buyer Matching: 9 foreign suppliers from AUSTRIA and 11 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $21.2M aggregated from 32 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
32 Verified Shipments
9 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists